last
two
decad
shown
increas
awar
fact
virus
occasion
cross
speci
barrier
lead
emerg
viral
diseas
new
host
speci
past
event
may
overlook
underli
caus
emerg
new
diseas
howev
advanc
diagnost
technolog
facilit
detect
recognit
new
emerg
virus
even
earli
stage
promin
exampl
hantaviru
haemorrhag
fever
virus
arbovirus
nipah
hendra
virus
avian
influenza
viru
ai
monkeypox
viru
coronaviru
cross
speci
barrier
one
anim
speci
anoth
readili
notic
associ
overt
patholog
known
zoonosi
case
viru
transmit
host
human
caus
diseas
cross
speci
barrier
unpredict
event
involv
complex
interact
viru
newli
adopt
host
hiv
viru
contemporari
human
influenza
virus
promin
exampl
virus
cross
speci
barrier
establish
perman
human
popul
without
depend
presenc
origin
anim
host
reservoir
fortun
natur
adapt
new
viru
lead
perman
establish
dissemin
within
human
popul
rare
event
often
viru
readili
adapt
infect
spread
effici
human
human
emerg
new
viral
infect
often
follow
environment
ecolog
technolog
chang
caus
human
activ
activ
may
lead
increas
contact
human
anim
host
act
reservoir
zoonot
virus
agricultur
develop
increas
exploit
environment
resourc
growth
increas
mobil
human
popul
trade
transport
food
livestock
identifi
import
factor
contribut
introduct
spread
number
new
virus
human
popul
road
map
transfer
may
differ
individu
virus
howev
common
underli
factor
affect
probabl
zoonot
event
identifi
tabl
potenti
virus
adapt
new
chang
cellular
environ
ecolog
nich
via
genet
variat
appear
key
featur
advent
novel
technolog
genet
modif
virus
offer
new
opportun
biomed
research
often
activ
involv
handl
virus
genet
modifi
variant
larg
quantiti
use
viral
vector
experiment
gene
therapi
live
vaccin
may
also
caus
concern
inde
activ
meet
primari
requir
transfer
ie
contact
infecti
virus
potenti
new
host
speci
therefor
import
identifi
activ
finit
risk
lead
new
viral
infect
practic
appropri
biosafeti
measur
review
risk
factor
associ
activ
viral
vector
address
perspect
emerg
virus
cross
host
barrier
natur
process
underli
transfer
expans
establish
virus
new
host
speci
depend
accumul
genet
chang
like
differ
variou
virus
may
affect
virtual
everi
aspect
viral
life
cycl
process
adapt
occur
varieti
mechan
includ
mutat
recombin
reassort
mutat
occur
genom
dna
well
rna
virus
gener
mutat
occur
slower
dna
virus
rna
virus
proofread
function
mani
dna
polymeras
correct
mistak
made
polymeras
replic
rna
genom
replic
rna
polymeras
lack
proofread
therefor
mutat
rna
virus
occur
frequent
dna
virus
consequ
rna
virus
gener
evolv
rapidli
lead
genet
heterogen
presenc
viral
quasispeci
concept
quasispeci
state
infect
host
viru
exist
popul
genet
relat
diverg
variant
defin
master
sequenc
complex
dynam
seri
mutant
sequenc
master
sequenc
remain
predomin
sequenc
present
within
popul
spectrum
mutant
may
shift
respons
select
pressur
quasispeci
popul
variant
may
select
expand
although
major
mechan
drive
adapt
base
accumul
point
mutat
evolut
virus
also
occur
recombin
recombin
occur
dna
rna
virus
lead
exchang
part
genom
may
result
emerg
new
viru
variant
recombin
take
place
least
cell
two
differ
viru
variant
requir
recombin
play
import
role
evolutionari
chang
dna
virus
case
recombin
virus
cellular
nucleic
acid
lead
captur
cellular
code
sequenc
reassort
anoth
import
evolutionari
mechan
rna
virus
segment
genom
influenza
virus
reovirus
cell
differ
strain
subtyp
genom
segment
may
shuffl
rearrang
progeni
viru
particl
result
gener
new
virus
differ
biolog
properti
offer
virus
larg
adapt
potenti
facilit
evolutionari
leap
respons
chang
cellular
environ
without
need
gradual
accumul
favour
mutat
late
new
syndrom
viral
enter
myocard
emerg
dog
subsequ
swept
rapidli
across
world
kill
thousand
dog
within
year
initi
appear
viru
name
canin
parvoviru
type
phylogenet
analysi
reveal
viru
remark
similar
felin
virus
felin
panleukemia
viru
fpv
infect
cat
mink
raccoon
dog
therefor
presum
emerg
natur
mutant
felin
parvoviru
properti
determin
capsid
protein
fpv
although
capabl
infect
felin
cell
cultur
viru
replic
cat
fpv
hand
abl
replic
dog
restrict
fashion
ie
bone
marrow
thymu
cultur
dog
cell
differ
fpv
two
nucleotid
substitut
within
capsid
gene
result
two
amino
acid
substitut
chang
associ
abil
bind
canin
transferrin
receptor
high
affin
result
acquir
capac
infect
canin
intestin
tissu
thought
subsequ
viru
acquir
transmiss
dog
adapt
replic
effici
dog
becam
pandem
interestingli
within
three
year
initi
appear
replac
worldwid
antigen
genet
variant
viru
indic
strong
select
advantag
anoth
antigen
variant
deriv
differ
two
amino
acid
aros
impli
variant
cpv
gradual
aros
due
adapt
select
dog
reaction
select
like
immunolog
pressur
two
new
variant
type
differ
amino
acid
isol
present
two
variant
still
endem
canin
popul
two
variant
virus
expand
host
rang
compar
origin
sinc
replic
cat
experiment
set
wild
although
rel
low
pathogen
remark
preval
new
antigen
variant
demonstr
wide
rang
felin
popul
worldwid
review
emerg
serv
exampl
rapid
global
distribut
establish
mutant
immunolog
new
host
wherea
like
aros
natur
mutant
deriv
cat
scenario
emerg
suggest
suggest
may
emerg
yet
unidentifi
anim
host
dog
may
arisen
select
growth
condit
fpv
vaccin
product
canin
cell
subsequ
spread
via
vaccin
high
titer
viru
shed
faec
resist
inactiv
may
explain
initi
rapid
dissemin
also
countri
strict
quarantin
regul
dog
human
activ
may
stimul
spread
mechan
transport
presum
aid
air
travel
aid
pandem
gener
accept
stem
viral
zoonosi
human
immunodefici
virus
emerg
separ
around
time
distinct
geograph
area
result
multipl
zoonot
transmiss
simian
immunodefici
viru
siv
primat
human
base
genom
organ
phylogenet
analys
clear
fall
two
differ
siv
lineag
implic
virus
must
distinct
origin
phylogenet
epidemiolog
evid
indic
evolv
consequ
sivcpz
transmiss
chimpanze
human
central
africa
howev
date
serolog
genet
evid
widespread
preval
strain
exist
chimpanze
wild
africa
transmiss
siv
sooti
mangabey
west
africa
probabl
caus
emerg
sinc
siv
strain
deriv
sooti
mangabey
phylogenet
close
relat
found
high
preval
sooti
mangabey
show
enorm
genet
divers
compris
three
genet
distinct
viru
group
n
predomin
group
consist
subtyp
clade
two
spread
throughout
world
contrast
mainli
confin
african
contin
compris
seven
distinct
phylogenet
lineag
subtyp
group
g
categor
epidem
subtyp
b
subtyp
c
g
estim
phylogenet
epidemiolog
data
initi
transfer
group
strain
progenitor
group
subtyp
may
taken
place
around
west
africa
may
initi
start
spread
africa
begin
therefor
two
decad
silent
transmiss
may
occur
africa
aid
becam
appar
hiv
identifi
caus
agent
earli
advent
hiv
epidem
earli
siv
strain
initi
may
cross
speci
barrier
result
increas
contact
human
simian
speci
appar
activ
hunt
handl
consumpt
contamin
uncook
simian
meat
led
direct
exposur
anim
blood
bodi
fluid
follow
year
passag
infect
human
partial
adapt
siv
strain
may
result
seri
cumul
mutat
genet
chang
larg
genet
differ
exist
siv
hiv
indic
initi
siv
strain
cross
speci
barrier
must
undergon
adapt
human
rel
short
period
time
suggest
involv
modern
iatrogen
event
massiv
vaccin
program
carri
time
use
inject
needl
may
provid
opportun
transmiss
adapt
viru
human
africa
genet
phenotyp
evolut
hiv
viru
still
proce
high
pace
individu
worldwid
also
within
infect
individu
infect
extens
genet
divers
origin
rapid
viral
turnov
replic
error
caus
revers
transcriptas
addit
among
global
pandem
group
sever
circul
recombin
form
crf
exist
crf
result
recombin
event
two
differ
strain
within
individu
constitut
newli
character
circul
strain
divers
allow
hiv
viru
rapidli
adapt
select
pressur
gener
antiretrovir
drug
host
immun
respons
select
hiv
variant
implic
use
differ
molecul
select
differ
cell
type
tissu
bodi
compart
lymph
node
brain
late
stage
infect
manifest
differ
diseas
pattern
emerg
hiv
exemplifi
multipl
independ
transmiss
simian
virus
associ
diseas
natur
host
eventu
result
establish
two
type
hiv
human
popul
adapt
new
host
viru
underw
myriad
molecular
chang
chang
social
behaviour
human
may
well
offer
opportun
newli
evolv
hiv
strain
becom
pandem
pandem
influenza
zoonot
diseas
caus
transfer
influenza
virus
anim
reservoir
twentieth
centuri
wit
three
influenza
pandem
spanish
influenza
asian
influenza
hong
kong
influenza
kill
million
peopl
worldwid
although
influenza
virus
isol
varieti
vertebr
includ
pig
hors
seal
whale
bird
serv
main
reservoir
potenti
sourc
new
pandem
strain
influenza
virus
contain
eight
rna
segment
code
least
ten
polypeptid
eight
structur
viral
protein
two
protein
influenza
virus
divid
subtyp
base
serolog
genet
differ
surfac
protein
encod
gene
respect
date
hemagglutinin
ha
subtyp
nine
subtyp
neuraminidas
na
protein
identifi
influenza
virus
contain
differ
combin
ha
na
subtyp
identifi
aquat
bird
human
influenza
virus
hemagglutinin
subtyp
neuramidas
subtyp
establish
perman
lineag
virus
consid
human
influenza
virus
natur
new
influenza
virus
emerg
via
two
mechan
antigen
variat
first
antigen
drift
caus
accumul
point
mutat
na
ha
surfac
protein
enabl
new
antigen
variant
virus
evad
human
immun
system
emerg
via
select
influenza
virus
emerg
via
antigen
drift
respons
yearli
epidem
human
popul
antigen
shift
occur
variant
influenza
viru
aris
antigenit
complet
distinct
former
circul
influenza
virus
new
viru
reassort
character
presenc
novel
hemagglutinin
gene
segment
alon
combin
complet
novel
neuraminidas
gene
segment
influenza
variant
emerg
antigen
shift
potenti
capabl
caus
novel
pandem
immunolog
human
popul
avirul
natur
avian
influenza
viru
infect
duck
waterfowl
result
adequ
adapt
host
avian
influenza
virus
replic
effici
human
similarli
human
influenza
virus
replic
effici
bird
trachea
tissu
pig
contain
receptor
avian
human
influenza
virus
therefor
permiss
human
avian
virus
thought
function
mix
vessel
reassort
human
avian
also
swine
influenza
virus
pig
therefor
also
consid
ecolog
nich
import
emerg
new
influenza
virus
human
pig
newli
reassort
virus
may
evolv
accumul
addit
mutat
adapt
mammalian
host
eventu
transmit
human
ampl
data
indic
adapt
human
cellular
environ
necessari
replic
effici
transmiss
human
adapt
polygen
basi
may
involv
multipl
viral
gene
segment
note
howev
rare
case
transmiss
lead
perman
establish
new
lineag
influenza
virus
human
analys
virus
caus
asian
hong
kong
pandem
reveal
caus
reassort
contain
mixtur
avian
human
genom
segment
genet
analysi
spanish
influenza
viru
initi
suggest
epidem
origin
whole
avian
influenza
viru
transmit
infect
pig
human
howev
origin
pandem
strain
still
remain
enigma
sinc
presenc
ha
molecul
origin
known
avian
strain
addit
evid
adapt
mammalian
host
hong
kong
epidem
direct
transmiss
whole
avian
virus
human
observ
analysi
viru
caus
epidem
reveal
reassort
influenza
viru
entir
avian
origin
cross
speci
barrier
appar
without
adapt
mammalian
host
interestingli
viru
abl
replic
human
acquir
transmiss
prevent
effici
spread
potenti
global
epidem
review
receptor
specif
consid
major
determin
host
rang
influenza
virus
ha
protein
play
pivot
role
receptor
recognit
attach
bind
sialic
acid
sa
host
cell
avian
influenza
virus
preferenti
bind
termin
sa
join
sugar
chain
glycoprotein
glycolipid
gut
howev
human
influenza
strain
bind
termin
sa
cell
respiratori
tract
result
acquir
mutat
hong
kong
avian
strain
howev
possess
avian
bind
properti
indic
receptor
specif
alon
absolut
requir
transmiss
host
rang
influenza
virus
determin
complex
interplay
multipl
factor
influenza
viru
illustr
unpredict
viru
variat
well
viru
great
potenti
adapt
regular
close
contact
bird
pig
human
offer
opportun
reassort
transfer
henc
market
asia
consid
risk
varieti
experiment
condit
appli
laboratori
propag
isol
virus
genet
modifi
deriv
result
virus
subject
select
forc
like
differ
experienc
natur
although
condit
may
well
defin
control
variou
select
pressur
gener
cultur
due
eg
chang
concentr
nucleotid
substrat
addit
mutagen
substanc
use
differ
incub
temperatur
incub
antibodi
chang
host
cell
differ
select
forc
unpredict
influenc
viru
sinc
cell
cultur
condit
profound
effect
composit
viral
popul
viral
stock
consist
genet
heterogen
popul
review
therefor
adapt
viru
cell
cultur
inevit
result
select
new
viru
variant
thu
experiment
condit
cell
cultur
repres
ecolog
virus
subject
select
forc
readili
evolv
yield
new
variant
alter
cell
tropism
host
rang
mous
hepat
viru
mhv
character
narrow
tissu
specif
vivo
vitro
specif
primarili
determin
viru
surfac
spike
glycoprotein
respons
attach
specif
receptor
mhv
viru
variant
alter
receptor
specif
broaden
host
rang
select
continu
passag
murin
mix
cultur
consist
murin
hamster
cell
mhv
acquir
abil
infect
human
hamster
monkey
cell
mhv
expans
attribut
presenc
viru
variant
recogn
homologu
normal
receptor
adapt
requir
mutat
surfac
protein
select
mutant
use
altern
cellular
receptor
select
variant
chang
receptor
specif
result
passag
cell
cultur
also
demonstr
diseas
viru
fmdv
specif
parent
viru
base
rgd
entri
pathway
rgd
motif
protein
sequenc
within
viru
capsid
recogn
bind
integrin
cell
surfac
host
cell
yet
upon
multipl
passag
cell
fmdv
variant
emerg
acquir
abil
infect
sever
initi
human
anim
cell
line
via
altern
entri
pathway
analysi
variant
reveal
adapt
fmdv
cell
cultur
led
enhanc
affin
heparan
sulfat
receptor
independ
rgd
motif
interestingli
variant
abl
maintain
infect
cell
cultur
independ
rgd
motif
also
without
requir
bind
heparin
sulfat
impli
use
altern
receptor
select
fmdv
mutant
associ
amino
acid
substitut
near
capsid
rgd
motif
recent
demonstr
passag
fmdv
cell
led
expans
tropism
primat
human
cell
line
select
variant
also
associ
amino
acid
substitut
viral
capsid
protein
less
data
mutat
frequenc
adapt
dna
virus
cell
cultur
compar
rna
virus
howev
number
illustr
exampl
adapt
polyomaviru
differ
cellular
environ
result
emerg
mutant
cell
cultur
review
random
mutagenesi
human
adenoviru
follow
repeat
passag
certain
cell
line
allow
isol
adenoviru
mutant
human
adenoviru
mutant
alter
specif
result
reduc
bind
affin
adenoviru
protein
integrin
cell
select
persist
infect
cell
line
recent
upon
passag
cell
cultur
adapt
led
emerg
herpesviru
mutant
virus
use
altern
receptor
replic
differ
cell
type
natur
host
cell
differ
speci
previous
sever
glycoprotein
essenti
entri
alphaherpesvirus
pseudorabi
viru
prv
herp
simplex
viru
hsv
bovin
herpesviru
review
interact
eg
viral
glycoprotein
c
gc
heparan
sulfat
mediat
primari
attach
infect
howev
secondari
interact
glycoprotein
gd
one
sever
entri
receptor
requir
singl
amino
acid
substitut
gd
glycoprotein
herp
simplex
well
complet
ablat
glycoprotein
swine
pseudorabi
viru
prv
led
gd
entri
mode
use
altern
receptor
least
three
class
protein
thought
involv
alphaherpesviru
entri
also
cell
cultur
adapt
human
cytomegaloviru
hcmv
betaherpesviru
result
select
phenotyp
variant
lost
endotheli
tropism
cell
cultur
virus
may
readili
adapt
mutat
select
competit
process
stochast
natur
adapt
therefor
unpredict
process
strongli
influenc
experiment
set
eg
multipl
infect
use
number
passag
employ
type
select
employ
one
awar
potenti
adapt
work
cell
cultur
advent
revers
genet
system
allow
gener
recombin
infecti
influenza
virus
entir
clone
cdna
cell
cultur
system
base
transfect
least
eight
plasmid
contain
copi
one
eight
influenza
viru
genom
segment
technolog
permit
gener
recombin
influenza
virus
reassort
contain
specif
heterolog
gene
segment
interest
offer
possibl
studi
biolog
properti
cellular
anim
model
system
addit
revers
genet
use
develop
vaccin
strategi
use
revers
genet
allow
deliber
introduct
specif
mutat
viral
gene
allow
select
evalu
contribut
individu
gene
segment
eg
viru
virulencepathogen
transmiss
host
rang
approach
alreadi
shown
pivot
gener
character
reassort
contain
heterolog
influenza
segment
eg
highli
pathogen
avian
influenza
hpai
strain
pandem
strain
addit
technolog
allow
gener
clone
segment
hpai
strain
caus
deadli
hong
kong
outbreak
revers
genet
system
also
use
altern
product
live
attenu
inactiv
vaccin
prepar
pandem
influenza
viru
threat
convent
annual
inactiv
vaccin
product
base
simultan
infect
chicken
egg
two
differ
influenza
strain
follow
select
desir
vaccin
viru
reassort
viru
contain
na
ha
segment
relev
circul
influenza
viru
background
six
complementari
segment
deriv
attenu
refer
strain
eg
apuerto
safe
human
overcom
difficulti
select
reassort
subsequ
labori
passag
virus
revers
genet
use
fast
direct
gener
vaccin
strain
vaccin
base
hpai
virus
use
revers
genet
anoth
import
advantag
highli
pathogen
virus
lethal
chicken
embryo
grown
larg
quantiti
way
viru
high
pathogen
associ
presenc
basic
amino
acid
adjac
cleavag
site
within
ha
molecul
use
recombin
dna
technolog
sequenc
elimin
revers
genet
use
gener
desir
vaccin
strain
contain
attenu
ha
molecul
conclus
revers
genet
enabl
gener
defin
reassort
influenza
virus
consist
eg
human
avian
viral
gene
segment
interest
howev
usual
possibl
predict
biolog
properti
gene
constel
variant
virus
activ
therefor
pose
potenti
risk
particular
gene
constel
base
character
isol
recombin
dna
technolog
allow
construct
infecti
cdna
clone
larg
rna
virus
coronavirus
includ
coronaviru
revers
genet
system
use
tool
product
defin
genet
modifi
coronavirus
allow
introduct
specif
mutat
genom
coronavirus
eg
exchang
specif
viral
gene
differ
coronavirus
studi
pathogenesi
replic
strategi
transmiss
possibl
engin
tissu
host
tropism
use
technolog
make
coronavirus
potenti
vector
vaccin
develop
possibl
gene
therapi
specif
coronavirus
primarili
determin
viru
entri
level
sever
studi
demonstr
sequenc
chang
gene
encod
coronaviru
surfac
spike
glycoprotein
lead
chang
tropism
specif
illustr
gener
chimer
coronaviru
target
recombin
ectodomain
glycoprotein
mous
hepat
viru
mhv
replac
ectodomain
glycoprotein
felin
infecti
periton
viru
fipv
substitut
confer
specif
tropism
felin
cell
abil
infect
murin
cell
lost
vice
versa
revers
genet
strategi
fipv
develop
confer
abil
infect
murin
cell
similar
techniqu
may
aid
studi
pathogen
exampl
mention
indic
use
recombin
dna
technolog
provid
power
system
gener
modifi
eg
highli
pathogen
virus
pandem
influenza
virus
live
attenu
viru
vaccin
among
success
viral
vaccin
known
date
tradit
attenu
achiev
jennerian
approach
ie
serial
passag
cell
cultur
method
number
use
vaccin
current
use
gener
still
mechan
attenu
phenotyp
evolv
larg
unknown
instanc
natur
degre
genet
variat
present
differ
stage
attenu
process
usual
known
presum
mechan
attenu
base
restrict
due
accumul
chang
surfac
glyco
protein
thu
select
variant
seem
inher
process
gener
desir
level
attenu
genet
stabil
prevent
revers
viru
therefor
depend
passag
histori
divers
within
viru
popul
like
repres
adapt
growth
cell
cultur
result
genet
variant
differ
phenotyp
may
present
vaccin
strain
viru
examin
substrain
live
attenu
vaccin
lot
base
yellow
viru
strain
measl
viru
edmonston
strain
demonstr
viru
stock
inde
consist
heterogen
popul
variant
number
advers
consequ
use
viru
stock
report
associ
possibl
select
growth
advantag
variant
recipi
therefor
caution
taken
releas
live
attenu
viral
vaccin
base
anim
virus
signific
progress
made
approach
genet
modifi
tropism
vector
virus
strategi
use
develop
cancer
gene
therapi
initi
vector
use
purpos
howev
improv
efficaci
virus
develop
use
viral
therapi
cancer
virotherapi
discuss
develop
human
adenoviru
type
wide
use
number
vector
applic
howev
use
genet
modifi
adenovir
vector
limit
efficaci
reli
presenc
receptor
car
coxackieviru
adenoviru
receptor
target
cell
primari
bind
viru
car
mediat
knob
domain
adenovir
fiber
protein
subsequ
intern
mediat
interact
rgd
motif
penton
base
viru
secondari
integrin
receptor
molecul
achiev
specif
high
efficaci
absenc
car
receptor
differ
strategi
develop
includ
redirect
adenovir
bind
altern
cellular
receptor
genet
modif
gene
code
capsid
protein
fiber
hexon
penton
base
may
result
either
expand
tropism
abolish
adenovir
nativ
tropism
tabl
summar
number
properti
contribut
rel
risk
use
vector
virus
purpos
numer
hazard
score
assign
properti
tabl
summar
number
adenovir
vector
alter
properti
rel
risk
modifi
virus
evalu
clinic
set
experiment
gene
therapi
tabl
illustr
chang
cell
tropism
tissu
tropism
host
rang
viral
vector
consid
factor
risk
assess
activ
genet
alter
vector
virus
gener
use
viral
vector
pose
special
concern
regard
unintend
spread
new
undesir
cell
type
well
horizont
transmiss
vector
vector
viru
alter
tropism
host
rang
virtual
constitut
new
viral
pathogen
potenti
new
diseas
manifest
natur
mani
factor
may
contribut
emerg
new
zoonot
viral
diseas
factor
consist
viral
evolutionari
process
mutat
natur
select
competit
host
determin
eg
immun
statu
physiolog
factor
environment
determin
ecolog
climatolog
circumst
highlight
emerg
new
viral
diseas
last
two
decad
process
adapt
often
involv
acquisit
alter
cell
tropism
host
rang
background
intensifi
use
virus
genet
modifi
variant
viral
gene
transfer
vector
biomed
research
experiment
gene
therapi
vaccin
caus
concern
review
highlight
import
identifi
evalu
risk
consequ
activ
may
gener
mutant
capac
transmiss
use
virus
may
lead
inadvert
introduct
vector
virus
chang
cell
tissu
tropism
andor
host
rang
immunolog
host
interact
viru
cellular
receptor
often
determin
host
rang
viru
therefor
constitut
speci
barrier
minor
mutat
viral
capsid
surfac
glycoprotein
may
alreadi
result
profound
chang
cell
tropism
host
rang
viru
review
therefor
focus
level
viru
entri
address
implic
activ
viral
vector
particular
mutant
could
contribut
ration
reason
inventori
factor
consid
risk
assess
activ
viral
vector
consid
possibl
risk
involv
handl
vector
virus
laboratori
awar
phenotyp
select
virus
cell
cultur
rais
possibl
risk
involv
must
mitig
adequ
biosafeti
measur
mani
virus
capabl
use
variou
receptor
impli
concept
barrier
specif
may
rather
flexibl
rigid
host
rang
complet
viral
life
cycl
exclus
restrict
level
entri
forc
entri
may
bypass
import
discriminatori
restrict
step
may
result
distinct
patholog
phenotyp
new
diseas
manifest
therefor
precaut
taken
avoid
inadvert
releas
spread
potenti
harm
vector
virus
goe
without
say
vaccin
among
effect
modal
control
viral
pathogen
evid
vaccin
benefit
higher
possibl
advers
effect
nevertheless
risk
associ
handl
vaccin
virus
viral
vector
exot
virus
small
finit
begin
understand
mechan
drive
emerg
new
virus
viral
diseas
natur
parallel
pattern
seen
emerg
viral
diseas
certain
viru
modif
gener
either
deliber
inadvert
handl
virus
laboratori
pattern
associ
risk
note
capac
viru
replic
spread
impli
risk
evalu
risk
laboratori
personnel
patient
also
effect
environ
includ
human
popul
weigh
evid
benefit
virus
maintain
extend
promin
role
wide
applic
entiti
clinic
veterinarian
use
